

Investigation of non-coding RNA gene polymorphisms LINC02952/LINC02953, LINC02747/LINC02952, LINC02664 in clear cell renal cell carcinoma patients
https://doi.org/10.25557/2073-7998.2025.07.123-125
Abstract
Сlear cell renal cell carcinoma (ccRCC) is a heterogeneous aggressive disease with a high mortality rate, so the search for risk markers is a relevant task. The material for the study was 128 DNA samples of ccRCC patients and 134 healthy individuals. It was revealed that the risk markers for ccRCC are rs11263432*T and rs793096*T alleles (OR=2.32 (95%CI=1.1–5.3) p=0.04 and OR=1.49 (95%CI=1.0-2.1) p=0.035, respectively).
About the Authors
A. K. ChumakovaRussian Federation
71, Prospekt Oktyabrya st., Ufa, 450054
I. R. Gilyazova
Russian Federation
71, Prospekt Oktyabrya st., Ufa, 450054;
3, Lenina st., Ufa, 450008
A. A. Izmaylov
Russian Federation
3, Lenina st., Ufa, 450008
E. A. Ivanova
Russian Federation
71, Prospekt Oktyabrya st., Ufa, 450054
M. A. Bermisheva
Russian Federation
71, Prospekt Oktyabrya st., Ufa, 450054;
3, Lenina st., Ufa, 450008
G. R. Abdeeva
Russian Federation
3, Lenina st., Ufa, 450008
V. N. Pavlov
Russian Federation
3, Lenina st., Ufa, 450008
E. K. Khusnutdinova
Russian Federation
71, Prospekt Oktyabrya st., Ufa, 450054;
3, Lenina st., Ufa, 450008
References
1. Gayyed M.F., Soliman M.M., El-Hussieny M. Clinical utility of MCM2 and CD44 expression in clear cell renal cell carcinoma. Pol J Pathol. 2020;71(4):339-346.
2. Herman A.B., Tsitsipatis D., Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell. 2022;82(12):2252-2266.
3. Purdue M.P., Dutta D., Machiela M.J. et al. Multi-ancestry genome-wide association study of kidney cancer identifies 63 susceptibility regions. Nat Genet. 2024;56:809–818.
4. Hon C.C., Ramilowski J.A., Harshbarger J. et al. An atlas of human long non-coding RNAs with accurate 5’ ends. Nature. 2017;543(7644):199-204.
5. Shen T., Miao S., Zhou Y. et al. Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3. Cell Commun Signal. 2022 ;20(1):152.
6. Ju X., Sun Y., Zhang F., et al. Long Non-Coding RNA LINC02747 Promotes the Proliferation of Clear Cell Renal Cell Carcinoma by Inhibiting miR-608 and Activating TFE3. Front Oncol. 2020;10:573789.
Review
For citations:
Chumakova A.K., Gilyazova I.R., Izmaylov A.A., Ivanova E.A., Bermisheva M.A., Abdeeva G.R., Pavlov V.N., Khusnutdinova E.K. Investigation of non-coding RNA gene polymorphisms LINC02952/LINC02953, LINC02747/LINC02952, LINC02664 in clear cell renal cell carcinoma patients. Medical Genetics. 2025;24(7):123-125. (In Russ.) https://doi.org/10.25557/2073-7998.2025.07.123-125